Cargando…
Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106261/ https://www.ncbi.nlm.nih.gov/pubmed/36752798 http://dx.doi.org/10.1097/CM9.0000000000002556 |
| _version_ | 1785026394490667008 |
|---|---|
| author | Deng, Zhenan Jin, Meiling Ou, Changxing Jiang, Wei Zhao, Jianping Liu, Xiaoxia Sun, Shenghua Tang, Huaping He, Bei Cai, Shaoxi Chen, Ping Wu, Penghui Liu, Yujing Kang, Jian Zhang, Yunhui Huang, Mao Xu, Jinfu Huang, Kewu Li, Qiang Zhang, Xiangyan Fu, Xiuhua Wang, Changzheng Shen, Huahao Zhu, Lei Shi, Guochao Qiu, Zhongmin Wen, Zhongguang Wei, Xiaoyang Gu, Wei Wei, Chunhua Wang, Guangfa Chen, Ping Xie, Lixin Lin, Jiangtao Tang, Yuling Han, Zhihai Chung, Kian Fan Zhang, Qingling Zhong, Nanshan |
| author_facet | Deng, Zhenan Jin, Meiling Ou, Changxing Jiang, Wei Zhao, Jianping Liu, Xiaoxia Sun, Shenghua Tang, Huaping He, Bei Cai, Shaoxi Chen, Ping Wu, Penghui Liu, Yujing Kang, Jian Zhang, Yunhui Huang, Mao Xu, Jinfu Huang, Kewu Li, Qiang Zhang, Xiangyan Fu, Xiuhua Wang, Changzheng Shen, Huahao Zhu, Lei Shi, Guochao Qiu, Zhongmin Wen, Zhongguang Wei, Xiaoyang Gu, Wei Wei, Chunhua Wang, Guangfa Chen, Ping Xie, Lixin Lin, Jiangtao Tang, Yuling Han, Zhihai Chung, Kian Fan Zhang, Qingling Zhong, Nanshan |
| author_sort | Deng, Zhenan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106261 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101062612023-04-17 Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies Deng, Zhenan Jin, Meiling Ou, Changxing Jiang, Wei Zhao, Jianping Liu, Xiaoxia Sun, Shenghua Tang, Huaping He, Bei Cai, Shaoxi Chen, Ping Wu, Penghui Liu, Yujing Kang, Jian Zhang, Yunhui Huang, Mao Xu, Jinfu Huang, Kewu Li, Qiang Zhang, Xiangyan Fu, Xiuhua Wang, Changzheng Shen, Huahao Zhu, Lei Shi, Guochao Qiu, Zhongmin Wen, Zhongguang Wei, Xiaoyang Gu, Wei Wei, Chunhua Wang, Guangfa Chen, Ping Xie, Lixin Lin, Jiangtao Tang, Yuling Han, Zhihai Chung, Kian Fan Zhang, Qingling Zhong, Nanshan Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-01-20 2023-02-08 /pmc/articles/PMC10106261/ /pubmed/36752798 http://dx.doi.org/10.1097/CM9.0000000000002556 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Deng, Zhenan Jin, Meiling Ou, Changxing Jiang, Wei Zhao, Jianping Liu, Xiaoxia Sun, Shenghua Tang, Huaping He, Bei Cai, Shaoxi Chen, Ping Wu, Penghui Liu, Yujing Kang, Jian Zhang, Yunhui Huang, Mao Xu, Jinfu Huang, Kewu Li, Qiang Zhang, Xiangyan Fu, Xiuhua Wang, Changzheng Shen, Huahao Zhu, Lei Shi, Guochao Qiu, Zhongmin Wen, Zhongguang Wei, Xiaoyang Gu, Wei Wei, Chunhua Wang, Guangfa Chen, Ping Xie, Lixin Lin, Jiangtao Tang, Yuling Han, Zhihai Chung, Kian Fan Zhang, Qingling Zhong, Nanshan Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title | Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title_full | Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title_fullStr | Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title_full_unstemmed | Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title_short | Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies |
| title_sort | eligibility of c-biopred severe asthma cohort for type-2 biologic therapies |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106261/ https://www.ncbi.nlm.nih.gov/pubmed/36752798 http://dx.doi.org/10.1097/CM9.0000000000002556 |
| work_keys_str_mv | AT dengzhenan eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT jinmeiling eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT ouchangxing eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT jiangwei eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhaojianping eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT liuxiaoxia eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT sunshenghua eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT tanghuaping eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT hebei eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT caishaoxi eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT chenping eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT wupenghui eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT liuyujing eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT kangjian eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhangyunhui eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT huangmao eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT xujinfu eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT huangkewu eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT liqiang eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhangxiangyan eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT fuxiuhua eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT wangchangzheng eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT shenhuahao eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhulei eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT shiguochao eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT qiuzhongmin eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT wenzhongguang eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT weixiaoyang eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT guwei eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT weichunhua eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT wangguangfa eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT chenping eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT xielixin eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT linjiangtao eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT tangyuling eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT hanzhihai eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT chungkianfan eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhangqingling eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies AT zhongnanshan eligibilityofcbiopredsevereasthmacohortfortype2biologictherapies |